Latest Breaking News On - Annual winter lung cancer conference - Page 1 : comparemela.com

Neoadjuvant Immunotherapy Is Helping Redefine Resectability in NSCLC

Neoadjuvant Immunotherapy Is Helping Redefine Resectability in NSCLC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNeelp chudgarMontefiore medical centerNational cancerTranslational researchVascular surgeryAlbert einstein collegeAnnual winter lung cancerThoracic surgeryEuropean journalAnnual winter lung cancer conference

Dr Olazagasti on a Case-Based Discussion of ALK-Mutated NSCLC Treatment

Coral Olazagasti, MD, discusses her participation in a case-based discussion at the 21st Annual Winter Lung Cancer Conference®.

United statesDivision of medical oncologyUniversity of miami miller school medicineDepartment of medicineCancer centerCoral olazagastiClinical medical oncologyMedical oncologyMiami miller schoolAnnual winter lung cancer conferencePatients with non small cell lung cancerCase based discussionAlk mutated

Continued ADC Development in NSCLC Necessitates Improved Knowledge of Mechanisms and Biomarker Optimization

Identifying biomarkers and the mechanism of action of antibody-drug conjugates may optimize benefits with these agents in non–small cell lung cancer.

United statesJohns hopkins universityDaiichi sankyoBenjamin levyJohns hopkins university school of medicineAnnual winter lung cancerMedical oncologyJohns hopkins sidney kimmel cancer centerSibley memorial hospitalJohns hopkins university schoolGold standardCare forResearch may identifyOptimal rolePatritumab deruxtecanLung cancer

Neoadjuvant vs Perioperative Immune Checkpoint Blockade in Resectable NSCLC: How Do We Choose?

Survival outcomes following curative resection in resectable NSCLC have been poor and, until recently, the main tool oncologists had at their disposal was neoadjuvant or adjuvant chemotherapy.

United statesPerioperative pembrolizumab keytrudaSamuel rosnerNeoadjuvant nivolumab opdivoUniversity of maryland greenebaum comprehensive cancer centerAnnual winter lungMaryland greenebaum comprehensive cancer centerMeets primary endAnnual winter lung cancer conferencePer winter lung cancer conferenceLung cancer

EGFR TKI–Based Combinations May Revolutionize Frontline EGFR+ NSCLC Management

Balazs Halmos, MD, discusses the FLAURA2 and MARIPOSA trials of EGFR TKIs plus chemotherapy in EGFR-mutated non–small cell lung cancer.

United statesNew yorkSouth koreaMontefiore einstein comprehensive cancer centerDepartment of medicine oncology hematologyDepartment of oncology medicalAnnual winter lung cancerMedical oncologyClinical scienceFirst lineAnnual winter lung cancer conferenceNatl cancerPatients with egfr mutated advanced non small cell lung cancerEgfr tkisWinter lungBalazs halmos